KT-253

Treatment Description

KT-253 is a kind of treatment called an MDM2 inhibitor. KT-253 may work by inhibiting proteins that cancer cells use to bypass the immune system to grow uncontrolled. 

Participating Centers

There are 10 centers running trials with this treatment. Enter a location below to find the closest center.